Medicare covers Zepbound for sleep apnea

This is a news story, published by CNBC, that relates primarily to Zepbound news.

Zepbound news

For more Zepbound news, you can click here:

more Zepbound news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Medicare drug plans

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest other obesity medications news, obesity drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

blockbuster obesity drug Zepbound

CNBC

•

Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says

Summary

Nutrition label

80% Informative

Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea.

That opens the door for broader coverage of and access to the drug, which is not currently covered by Medicare and many other insurance plans for weight loss specifically.

The Biden administration in November proposed a rule that would allow Medicare and Medicaid to cover weight loss drugs for patients with obesity.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech